Pazopanib for the treatment of soft-tissue sarcoma

Pazopanib for the treatment of soft-tissue sarcoma

Pierre Heudel,1 Philippe Cassier,1 Olfa Derbel,1 Armelle Dufresne,1 Pierre Meeus,2 Philippe Thiesse,3 Dominique Ranch&egrave;re-Vince,4 Jean Yves Blay,1 Isabelle Ray-Coquard1,51Department of Medical Oncology, 2Department of Surgical Oncology, 3Department of Radiology, 4Department of Patholog...

Full description

Bibliographic Details
Main Authors:	Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranch&egrave;re-Vince D, Blay JY, Ray-Coquard I
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-10-01
Series:	Clinical Pharmacology: Advances and Applications
Online Access:	http://www.dovepress.com/pazopanib-for-the-treatment-of-soft-tissue-sarcoma-a11370

Similar Items

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).
by: Olfa Derbel, et al.
Published: (2017-01-01)

Trabectedin and its potential in the treatment of soft tissue sarcoma
by: Philippe A Cassier, et al.
Published: (2008-03-01)

Pazopanib in the management of advanced soft tissue sarcomas
by: Cranmer LD, et al.
Published: (2016-06-01)

The role of Pazopanib in Soft Tissue Sarcoma: A comprehensive review of the literature
by: Fotopoulos George, et al.
Published: (2015-09-01)

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
by: Axel Le Cesne, et al.
Published: (2019-08-01)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
by: Mélodie Carbonnaux, et al.
Published: (2019-04-01)

Effect of Acid‐Suppressive Strategies on Pazopanib Efficacy in Patients With Soft‐Tissue Sarcoma
by: Sorana G. Pisano, et al.
Published: (2019-09-01)

Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
by: Stefanie L. Groenland, et al.
Published: (2018-12-01)

PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
by: Sang Kyum Kim, et al.
Published: (2021-03-01)

Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
by: Laura Molenaar-Kuijsten, et al.
Published: (2021-11-01)

Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
by: Hee Jin Cho, et al.
Published: (2024-01-01)

Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
by: Takeshi Aoyama, et al.
Published: (2023-02-01)

Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
by: Yasuyoshi Sato, et al.
Published: (2021-12-01)

Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
by: Marie-Sophie Minot-This, et al.
Published: (2022-06-01)

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature
by: Yoshiro Nakahara, et al.
Published: (2017-04-01)

Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma
by: Steven Attia, et al.
Published: (2015-05-01)

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis
by: Que Y, et al.
Published: (2018-07-01)

Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunction
by: Kazuki Okubo, et al.
Published: (2018-09-01)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
by: Mina Fazel, et al.
Published: (2023-03-01)

Molecular Mechanisms of Kaposi Sarcoma Development
by: Andy Karabajakian, et al.
Published: (2022-04-01)

Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
by: Pooja Shah, et al.
Published: (2020-09-01)

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
by: Eijiro Shimada, et al.
Published: (2021-10-01)

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells
by: Hee Kyung Kim, et al.
Published: (2016-06-01)

Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
by: Mirili C, et al.
Published: (2019-04-01)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
by: Gyuhee Seong, et al.
Published: (2023-03-01)

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases
by: William L. Read, et al.
Published: (2016-10-01)

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic <sup>18</sup>F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group
by: Christos Sachpekidis, et al.
Published: (2019-06-01)

Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study
by: Timo Gaiser, et al.
Published: (2021-07-01)

Safety and efficacy of pazopanib as a second-line treatment and beyond for soft tissue sarcomas: A real-life tertiary-center experience in the MENA region
by: Nour Abdul Halim, et al.
Published: (2021-01-01)

Efficacy of Pazopanib in the Treatment of Metastatic Malignant Giant Cell Tumor of Soft Tissue: A Case Report
by: Tadashi Iwai, et al.
Published: (2022-01-01)

Management and outcome of acral soft-tissue sarcomas
by: Dean, B, et al.
Published: (2018)

Bone and Soft Tissue Sarcoma
by: Antonio Ruggiero
Published: (2020-09-01)

Retroperitoneal soft tissue sarcoma
by: Gutiérrez Carolina, et al.
Published: (2007-02-01)

Trabectedin in Soft Tissue Sarcomas
by: Bradley J. Petek, et al.
Published: (2015-02-01)

Soft tissue sarcomas of the kidney
by: Olivia Köhle, et al.
Published: (2015-03-01)

Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.
by: Manojkumar Bupathi, et al.
Published: (2017-01-01)

Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
by: Bruce Sabath, et al.
Published: (2018-10-01)

The proteomic landscape of soft tissue sarcomas
by: Jessica Burns, et al.
Published: (2023-06-01)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
by: Koliou P, et al.
Published: (2018-02-01)

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation
by: Kazuhiro Tanaka, et al.
Published: (2019-01-01)